Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations

Supportive Care in Cancer

Volumn 22, Issue 5, 2014, Pages 1161-1169

  Griffith, Kathleen A ^a   Couture, Darren J ^b   Zhu, Shijun ^a   Pandya, Naimish ^c   Johantgen, Mary E ^a   Cavaletti, Guido ^d   Davenport, Joan M ^a   Tanguay, Lori J ^f   Choflet, Amanda ^e   Milliron, Todd ^f   Glass, Erica ^g   Gambill, Nancy ^f   Renn, Cynthia L ^a   Dorsey, Susan G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c MEDIMMUNE   (United States)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^g St Agnes Cancer Institute   (United States)

Author keywords

Cancer; Chemotherapy; Chemotherapy induced peripheral neuropathy; CIPN; Pain; Quality of life

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GRIP STRENGTH; HUMAN; MALE; MIDDLE AGED; NEUROPATHIC PAIN; NEUROPATHIC PAIN SCALE; NEUROTOXICITY; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PERCEPTIVE THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SENSORY NERVE; TENDON REFLEX;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; QUALITY OF LIFE; SELF REPORT; SENSORY THRESHOLDS;

EID: 84897485050     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2068-0     Document Type: Article

References (44)

1. Edwards BK et al (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19):1407-1427 (Pubitemid 41520077)
2. World Health Organization (2001) International Classification of Functioning, Disability, and health (ICF)
3. Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24(10):1633-1642 (Pubitemid 46638788)
4. Mielke S, Sparreboom A, Mross K (2006) Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 42(1):24-30 (Pubitemid 41814529)
5. Postma TJ, Heimans JJ (2000) Grading of chemotherapy-induced peripheral neuropathy. Ann Oncol 11(5):509-513 (Pubitemid 30431370)
6. Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9-17 (Pubitemid 34119018)
7. Chaudhry V et al (1994) Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy. Neurology 44(8):1459-1462 (Pubitemid 24247437)
8. Polomano RC et al (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94(3):293-304 (Pubitemid 33145399)
9. Roytta M, Raine CS (1985) Taxol-induced neuropathy: further ultrastructural studies of nerve fibre changes in situ. J Neurocytol 14(1):157-175
10. Dougherty PM et al (2004) Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109(1-2):132-142 (Pubitemid 38479779)
11. Fischer SJ et al (2001) Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol Dis 8(6):1027-1035 (Pubitemid 34017096)
12. Andre T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343-2351 (Pubitemid 38702845)
13. Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176-181 (Pubitemid 36962641)
14. Oken MM et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649-655 (Pubitemid 13149996)
15. Miller AB et al (1981) Reporting results of cancer treatment. Cancer 47(1):207-214 (Pubitemid 11167383)
16. Cavaletti G et al (2006) Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst 11(2):135-141 (Pubitemid 43894080)
17. Wolf S et al (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44(11):1507-1515
18. Ma L et al (2012) Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic painmodels. J Pharmacol Sci 119(3):282-286
19. Matsumoto M et al (2006) Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test. Mol Pain 2:16
20. Matsumoto M et al (2008) Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain 4:25
21. Koga K et al (2005) Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation. Mol Pain 1:13
22. Katims JJ et al (1987) Constant current sine wave transcutaneous nerve stimulation for the evaluation of peripheral neuropathy. Arch Phys Med Rehabil 68(4):210-213 (Pubitemid 17065356)
23. Takekuma K et al (2000) Age and gender differences in skin sensory threshold assessed by current perception in community dwelling Japanese. J Epidemiol 10(1):S33-S38
24. Rendell MS et al (1989) Mapping diabetic sensory neuropathy by current perception threshold testing. Diabetes Care 12(9):636-640 (Pubitemid 19240515)
25. Rendell MS et al (1989) A comparison of nerve conduction velocities and current perception thresholds as correlates of clinical severity of diabetic sensory neuropathy. J Neurol Neurosurg Psychiatry 52(4):502-511 (Pubitemid 19104510)
26. Masson EA, Boulton AJ (1991) The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med 8(Spec No):S63-S66
27. Nishimura H et al (2004) Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer. Gan To Kagaku Ryoho 31(4):627-630
28. Tack CJ et al (1994) Comparison of clinical examination, current and vibratory perception threshold in diabetic polyneuropathy. Neth J Med 44(2):41-49 (Pubitemid 24053979)
29. Doi D et al (2003) Evaluation of the neurotoxicity of paclitaxel and carboplatin by current perception threshold in ovarian cancer patients. J Nihon Med Sch 70(2):129-134 (Pubitemid 36553971)
30. Rolke R, Baron R, Maier C et al (2006) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123(3):231-243
31. Cavaletti G et al (2013) The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24(2):454-462
32. Galer BS, Jensen MP (1997) Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 48(2):332-338 (Pubitemid 27087598)
33. Calhoun EA et al (2003) Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer 13(6):741-748 (Pubitemid 38235217)
34. Huang HQ et al (2007) Validation and reduction of FACT/GOG-Ntx subscale for platinum/paclitaxel-induced neurologic symptoms: a gynecologic oncology group study. Int J Gynecol Cancer 17(2):387-393 (Pubitemid 46426765)
35. Bell-Krotoski JA et al (1995) Threshold detection and Semmes-Weinstein monofilaments. J Hand Ther 8(2):155-162
36. de Sonnaville JJ et al (1997) The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting. Diabetes Res Clin Pract 35(2-3):149-156
37. Felix E, Widerstrom E (2009) Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain. J Rehabil Res Dev 46:69-84
38. Hilz MJ, Dutsch M, Neundorfer B (1998) Autonomic disorders in polyneuropathies. Med Klin (Munich) 93(9):533-540
39. Martina IS et al (1998) Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry 65(5):743-747 (Pubitemid 28486656)
40. Merkies IS et al (2000) Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies. The Inflammatory Neuropathy Cause and Treatment (INCAT) Group. J Neurol Neurosurg Psychiatry 68(5):669-671 (Pubitemid 30248840)
41. Smieja M et al (1999) Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research. J Gen Intern Med 14(7):418-424 (Pubitemid 29344617)
42. Hallett M (1993) NINDS myotatic reflex scale. Neurology 43(12):2723
43. Richardson JK (2002) The clinical identification of peripheral neuropathy among older persons. Arch Phys Med Rehabil 83(11):1553-1558
44. Fauci AS et al (ed) (2012) Harrison's principles of internal medicine, 18ed.